Black HD Patients Benefit More from Obesity
Obesity is associated with greater survival in African-American maintenance hemodialysis (MHD) patients compared with other races, according to a study.
Renal Week 2009
Steroids May Harm Athletes’ Kidneys
Serious renal damage is a possible consequence of long-term abuse of anabolic steroids, data show .
Earlier May Not Be Better For Preemptive Transplant
SAN DIEGO—Pre-dialysis transplant recipients with a high level of kidney function do not appear to benefit from their transplant more than pre-dialysis recipients with a low level of kidney function, data show.
Researchers Link Elevated PTH to High Uric Acid
Elevated serum parathyroid hormone levels are associated with higher serum uric acid levels in the U.S. adult population, investigators reported at ASN’s Renal Week 2009.
Specialty Pharmacy Improves Control of Secondary Hyperparathyroidism
Participation in a specialty pharmacy improved control of secondary hyperparathyroidism in hemodialysis patients, researchers reported at ASN’s Renal Week 2009.
Cinacalcet Safely Treats Persistent Post-Kidney-Transplant Hyperparathyroidism
Cinacalcet therapy is safe and effective for treating persistent hyperparathyroidism after renal transplantation, British researchers reported at ASN’s Renal Week 2009. The medication is not associated with allograft dysfunction or significant adverse effects.
Elevated Parathyroid Hormone Linked to Obesity in CKD Patients
Obesity in CKD patients is associated with increased parathyroid hormone levels independent of estimated glomerular filtration rate, according to a study presented at ASN’s Renal Week 2009.
Diagnosing Acute Kidney Rejection through Urinary Proteome Analysis
It may be possible to detect acute allograft rejection in kidney transplant patients by urinary proteome analysis, according to a new German study that was presented at ASN’s Renal Week 2009.
Risk Factors for New-Onset Diabetes in Pediatric Transplant Patients Identified
Among pediatric renal transplant recipients, increased age and having a very high or very low BMI, steroid use at the time of hospital discharge are three independent factors associated with an increased risk of new onset diabetes, according to new data presented at ASN’s Renal Week 2009.
Intensified Dosing Regimen May Lower Rejection Rate
An intensified-dosing regimen of enteric-coated mycophenolate sodium in combination with basiliximab and standard doses of cyclosporine may result in a lower rate of rejection without compromising safety and tolerability, according to new data presented at ASN’s Renal Week 2009.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...